Tải bản đầy đủ (.pptx) (34 trang)

Bệnh mạch vành ổn định với tổn thương nhiều nhánh ở người có bệnh thận mạn Khi nào nên can thiệp

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (2.62 MB, 34 trang )

Stable CKD: when do we need PCI?
G )contilia

i

Heart and Vascular Center

Christoph K. Naber
Contilia Heart and Vascular


Conflicts of Interest

Nothing to declare

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


Stages of CKD

Sarnak et al. Circulation 2003
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


C.,)contilia

i Heart

CKD and Mortality

and Vascular Center



Cardiovascularmortalityin the general population(NCHS) and
in

kidneyfailuretreated

by dialysisor transplant(USRDS)

-+-GP
---

-

Male
GP Fermle

----..- GP Black

·-

_.
---0---

GP White
Dialysis Male

-o-Dialysis Fermle

c


-tr-

Dialysis Black

u
c:

---&-

Dialysis White

~

----*- Transplant

c:

<(
25-34

35-44

45-54

55-64

65-74

75-84


>85

Age {years)

Sarnak et al. Circulation 2003
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


CKD and Cardiovascular

Disease

Sarnak et al. Circulation 2003
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


CKD and MACE
N=16.958

Di Angelantonio et al.
BMJ 2010
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


How should I treat?

67 year old patient on hemodialysis
Symptoms: progressive over 3 months (CCS II, NYHA III)
Echo: hypokinesia of inferior wall, EF 45%
Laboratory: mildly elevated Troponin T (0.2 µg/l)

ECG: SR 70 and RBB

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


How should I treat?

67 year old patient on hemodialysis
Symptoms: progressive over 3 months (CCS II, NYHA III)
Echo: hypokinesia of inferior wall, EF 45%
Laboratory: mildly elevated Troponin T (0.2 µg/l)
ECG: SR 70 and RBB

Stable or instable patient?
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


&)contilia

Serum phosphorus and cardiac injury
0.25

y=0.037x-0.026

y=132.1x-98.4
600

R2=0.189 p=0.00

0.20




E o.rs



--

en

en
c:

R2=0.348 p=0.00

R2=0.16 p=0.00

c:

>-

-u

:E

0.05

0.00


8

-

2

3

20000

:z
0...

cc

200

0
0

~
0

400

C>

1--

30000

0

..s

;::::: 0.10

4

Heart and Vascular Center

y=467Sx-4684

40000

=E



r)

0

2

3


10000

0


0

-

e

4

0

2

3

4

n

300

y=38.3x+67.4
R2=0.16 p=0.00



.;.

E
-9


-:E

::;

••
~

200

R2=0.006 p=0.19

80

R2=0.095 p=0.01



80

u....

y=1.78x+ 1.96

0

100

250
N


100

y=-8.7x+75.7

=3 60

0

cc

::;



LU

150

60

~

40

::

20

::.::


100



..

\...J

40

so

0

0

0





0



0

0.5


1.0

1.5

2.0

2.5

3.0

0.5

1.0

1.5

2.0

2.5

3.0

0

2

3

4


Serum phosphorus (mmol/L)

Wang et al.
Med Sci Mon 2014
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


Phosphate and CMC Apoptosis

Wang et al.
Med Sci Mon 2014
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


Troponin and prognosis in CKD
Metaanalysis of 124 trials adjustng for age and CAD

Michos et al. AHRQ Publication No. 14-EHC030-EF 2014
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


How should I treat?

67 year old patient on hemodialysis
Symptoms: progressive over 3 months (CCS II, NYHA III)
Echo: hypokinesia of inferior wall, EF 45%
Laboratory: mildly elevated Troponin T (0.2 µg/l)
remaining stable after 3 and 12 hours
ECG: SR 70 and RBB


Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


How should I treat?

67 year old patient on hemodialysis
Symptoms: progressive over 3 months (CCS II, NYHA III)
Echo: hypokinesia of inferior wall, EF 45%
Laboratory: mildly elevated Troponin T (0.2 µg/l)
remaining stable after 3 and 12 hours
ECG: SR 70 and RBB

Coronary angiography indicated?
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


CKD and Coronary Angiography
N=3.637 patents

Table: GFR < 60 ml/min/1.73 m2

Na et al.
J Korean Med Sci 2009
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


Platelet activation in CKD
306 patents with diabetes mellitus on DAPT


Angiolillo et al.
JACC 2010
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


GFR and outcome after PCI
13.307 patents from 5 TIMI trials with NSTEMI-ACS

Gibson et al. EHJ 2004
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


NSTEMI ACS & early angio in CKD

Charytan et al. Clin J Am Soc Nephrol 2009
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


How should I treat?

67 year old patient on hemodialysis
Symptoms: progressive over 3 months (CCS II, NYHA III)
Echo: hypokinesia of inferior wall, EF 45%
Laboratory: mildly elevated Troponin T (0.2 µg/l)
remaining stable after 3 and 12 hours
ECG: SR 70 and RBB

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany



Need for revascularizaton?
Symptomatic indication:
is the patient already on optimal medical therapy?

COURAGE: Boden et al. NEJM 2007
Contilia Heart- and Vascular

Center, Elisabeth Krankenhaus Essen, Germany


Need for revascularizaton?
Prognostic indication:
ischemic burden > 10%?

COURAGE NUCLEAR SUBSTUDY:
Shaw et al. Circulation 2008
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


CKD in randomized trials* on CAD

Trials where CKD is exclusion criterion

Trials reporting CKD as baseline condition

*(86 trials randomizing 411 653 patients)

Charytan et al. Kidney Int 2006
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany



C.,)contilia

i Heart and Vascular Center

CABG vs. PCI in HD patients
Table 6. Comparison of CABG and PCI in HD Patients
Freedom From

In-Hospital
Mortality (%)

n
Study (Ref.)

CABG

PCI

CABG

Rinehart et al. (95)

60

24

Koyanagi et al. (109)

23


20

Event-Free
Survival (%)

Angina(%)

PCI

CABG

PCI

77

60

CABG
66

(6 mo)
0

PCI
51
(2 yrs)

0


18

70
(5 yrs)

Simsir et al. (110)

19

22

4.5

5.3

87

40

67

(1.5 yr)

Herzog et al. (111)

7,419

6,887

12.5


69
(1.5 yr)

5.4

71

62
(2 yrs)

Agirbasli et al. (112)

130

122

6.9

1.6

27

23
(1 yr)

Ivens et al. (113)

65


40

4.8

0

90

29

86

(2 yrs)

Herzog et al. (114)

6,668

4,836

t/1

(4,280)

8.6

6.4

t/1


82
(2 yrs)
48

56

t/1 (48) (2

(4.1%)

yrs)

Ix et al. (115)*

290

t/1

(all)

72.7t

71.5
(3 yrs)

"Arterial Revascularization Therapies Study substudy; tend point was combined incidence of death, myocardial infarction, or stroke.

t/J = stents; PCI = percutaneous coronary intervention. Other abbreviations as in Table 5.

Gupta et al.

JACC 2004
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


C.,)contilia

i

PCI vs. CABG in CKD: all events
Table 6:

Comparison of cumulative events between ESRD patients who underwent

CABG

Study or subgroup

Total

Agirbasli et al. (2000) [9]

51

130

Aoki et al. {2003) (15]

26

55


Ashrith et al. (2010) (1

OJ
23

Chertow et al. {2000) (20]

14

Hemmelgarn et al. (2004) (49]

93

153

Herzog et al. (1999) [6]

20

65

Koyanagi et al. (1996) [7]

34

8

Simsir et al. {1998) (19]


9
29

Szczech et al. {2001) (50]

Total {95% Cl)
events

10876

6961

17194

49.4

0.78 {0.73-0.84) Ivens

0.06 {0.01-0.32)

18

13

0.10 {0.02-0.44)

0.3

0.2


2.04 {0.71-5.90)
24

16

244

I

0.08 {0.03-0.22)

10

75

0.55 {0.21-1.40)

0.59 {0.54-0.64)

42.3

0.4

92

22

0.3

9116


0.9

60

0.74 {0.30-1.79)

1.45 {0.92-2.29)
6887

20

27
92

15 156

6668

74
34

6

5823

28

47


Rinehart et al. (1995) (18]

Sunagawa et al. {2010) [22]

7419

18
3

42

0.9

0.3

2.93 {1.57-5.47)

0.3

46

Odds ratio
M-H, Random {95% Cl)

0.04 {0.01-0.14)
33

322

M-H, Random {95% Cl)


0.57 (0.34-0.93)

0.9
14

29

40

23

Manabe et al. {2009) [14]
Ohmoto et al. {1999) [17]

70

22

147

4774

1.2

54

29

5662


Herzog et al. {2002)[13]
et al. {2001) (21]

67

Weight{%)

Total

122

65

130

76

Odds ratio

Events

19

Charytan et al. {2006) (16]

CABG or PCI

PCI


Events

Heart and Vascular Center

0.2

19
0.4

75

100.0

1.11
0.3

{0.43-2.87)
0.13 {0.03-0.58)

0.46 {0.17-1.28)
163

1.7

0.71 {0.47-1.06)

0.1

10


Favours CABG

0.01

Favours PCI

100

0.69 {0.65-0.73) Total

13 324

Zheng et al.
EJCTS 2012

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany


PCI vs. CABG in CKD: repeat revascularization

Zheng et al.
EJCTS 2012
Contilia Heart-

and Vascular Center, Elisabeth Krankenhaus Essen, Germany


PCI vs. CABG in CKD: myocardial infarction

Zheng et al.

EJCTS 2012
Contilia Heart-

and Vascular Center,

Elisabeth Krankenhaus Essen, Germany


×